The involvement of interleukins in signaling in AS is well studied, especially for the IL-23/IL-17 axis, which plays a role in the Th17 immune response and has been previously associated with many immune-mediated inflammatory diseases, including RA, PsO, IBD, and MS. This evidence concerns the gene IL23A and inflammatory bowel disease.